RTA Laboratuvarlari Biyolojik (RTALB) — Capital Reinvestment Ratio
RTA Laboratuvarlari Biyolojik (RTALB) has a Capital Reinvestment Ratio of 0.13x as of June 2025, meaning it reinvests 0% of its operating cash flow (TL20.98 Million) in capital expenditures (TL2.68 Million). Check how tangible is RTA Laboratuvarlari Biyolojik's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
RTA Laboratuvarlari Biyolojik Capital Reinvestment Ratio (2010–2023)
This chart tracks RTA Laboratuvarlari Biyolojik's Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of RTA Laboratuvarlari Biyolojik.
Annual Capital Reinvestment Ratio for RTA Laboratuvarlari Biyolojik (2010–2023)
Year-by-year Capital Reinvestment Ratio for RTA Laboratuvarlari Biyolojik from 2010 to 2023. See how much free cash does RTA Laboratuvarlari Biyolojik generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (TRY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.67x | TL72.41 Million | TL48.48 Million | ▲ +114.8% |
| 2021 | 0.31x | TL68.78 Million | TL21.43 Million | ▼ -81.7% |
| 2020 | 1.70x | TL9.37 Million | TL15.96 Million | ▲ +17.4% |
| 2019 | 1.45x | TL3.58 Million | TL5.19 Million | ▲ +540.2% |
| 2017 | 0.23x | TL1.41 Million | TL318.64K | ▼ -73.2% |
| 2016 | 0.85x | TL2.86 Million | TL2.42 Million | ▲ +213.5% |
| 2015 | 0.27x | TL6.18 Million | TL1.67 Million | ▲ +9.1% |
| 2014 | 0.25x | TL2.58 Million | TL640.00K | ▼ -70.8% |
| 2013 | 0.85x | TL11.26 Million | TL9.56 Million | ▼ -9.3% |
| 2012 | 0.94x | TL2.24 Million | TL2.09 Million | ▲ +349.9% |
| 2011 | 0.21x | TL1.61 Million | TL335.00K | ▲ +6.7% |
| 2010 | 0.19x | TL2.78 Million | TL541.00K | — |